GlassScriptPhysician profile
Philip Morris Bach
NPI 1376594267
$1,455.24
in general payments reported to CMS, 2019-2025
17 companies · $72.34 in 2025
The $72.34 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $195 · 2021: $136 · 2022: $121 · 2023: $245 · 2024: $227 · 2025: $72.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $249.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $247.13 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.00 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $202.70 | 2019-2024 | |
| Pfizer INC. | $118.51 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $100.14 | 2021-2022 | |
| Biotronik INC. | $95.44 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $37.70 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $35.19 | 2023 | Eliquis |
| Merck Sharp & Dohme LLC | $22.48 | 2021 | |
| Novo Nordisk INC | $21.36 | 2024 | Wegovy |
| Philips North America LLC | $19.37 | 2020 | |
| Arbor Pharmaceuticals, INC. | $18.70 | 2021 | |
| Heartflow, INC. | $18.33 | 2024 | |
| Lundbeck LLC | $15.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.57 | 2021 | |
| Infobionic, INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.